Pitt collaborative receives $7 million for COVID-19 outpatient convalescent plasma therapy

(University of Pittsburgh) A team of University of Pittsburgh, Michigan Medicine, Medical University of South Carolina and Stanford Medicine. researchers were recently awarded funds from the National Heart, Lung, and Blood Institute in collaboration with Biomedical Advanced Research and Development Authority, part of Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services totaling more than $7 million to study the role of convalescent plasma in mitigating symptoms of COVID-19.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news